Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio Q&A
Pharma & Biotech
Revolutionizing ADCs: A Q&A with BioLoomics Founder Doug Chapnick on Innovation and New CSO Appointment
Dr. Doug Chapnick, CEO of BioLoomics, discusses their mission to improve antibody-drug conjugates (ADCs) for cancer treatment, their technology validation efforts, AI exploration, and the hiring of new CSO Kurt Gish.
June 13, 2024
DeciBio Q&A
Pharma & Biotech
Revolutionizing ADCs: A Q&A with BioLoomics Founder Doug Chapnick on Innovation and New CSO Appointment
Dr. Doug Chapnick, CEO of BioLoomics, discusses their mission to improve antibody-drug conjugates (ADCs) for cancer treatment, their technology validation efforts, AI exploration, and the hiring of new CSO Kurt Gish.
June 13, 2024
adjuvant cell therapy
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | May Roundup 2024
May was a productive month for Liquid Biopsy (LBx). In particular, there were a number of notable clinical and regulatory updates.
June 11, 2024
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | May Roundup 2024
May was a productive month for Liquid Biopsy (LBx). In particular, there were a number of notable clinical and regulatory updates.
June 11, 2024
Liquid Biopsy
.png)
Newsletter Update
Digital Health and Informatics | Q4 2023 – Q1 2024 Update
With this issue, we offer a synthesis of exciting and impactful regulatory updates, product approvals, funding rounds, and M&A activity in the digital health space from the end of 2023 through Q1 2024.
June 4, 2024
Newsletter Update
Digital Health and Informatics | Q4 2023 – Q1 2024 Update
With this issue, we offer a synthesis of exciting and impactful regulatory updates, product approvals, funding rounds, and M&A activity in the digital health space from the end of 2023 through Q1 2024.
June 4, 2024
Digital Health
Health Technology Market
Women's Health
Medical Devices
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | May Roundup 2024
Read about the latest updates in the Next-Generation Therapeutics space in the month of May.
June 3, 2024
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | May Roundup 2024
Read about the latest updates in the Next-Generation Therapeutics space in the month of May.
June 3, 2024
Next-Generation Therapeutics
DeciBio Q&A
Pharma & Biotech
Jason Foster on Ori Biotech and the Path to Viability
We had the pleasure of discussing the booming field of cell therapies with Jason Foster, CEO of Ori Biotech.
May 21, 2024
DeciBio Q&A
Pharma & Biotech
Jason Foster on Ori Biotech and the Path to Viability
We had the pleasure of discussing the booming field of cell therapies with Jason Foster, CEO of Ori Biotech.
May 21, 2024
Cell & Gene Tx
Infographic
Clinical Diagnostics
DeciBio NGS DxBook 2024 - MRD Testing
We are thrilled to announce the 2024 edition of the NGS DxBook, packed with updated data and expanded insights!
May 16, 2024
Infographic
Clinical Diagnostics
DeciBio NGS DxBook 2024 - MRD Testing
We are thrilled to announce the 2024 edition of the NGS DxBook, packed with updated data and expanded insights!
May 16, 2024
DeciBio News
DxBooks Data Insights
MRD Testing
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved